The Impact of Exercise Training on Functional Capacity in Heart Failure
Impact of Exercise Training on Functional Capacity in Heart Failure Patients With Preserved Ejection Fraction.
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose of this study is to determine whether exercise training will improve functional capacity in patients with heart failure and preserved ejection fraction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2011
CompletedFirst Posted
Study publicly available on registry
February 2, 2011
CompletedStudy Start
First participant enrolled
March 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedMarch 19, 2012
March 1, 2012
1.8 years
January 26, 2011
March 16, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline of peak oxygen uptake on graded exercise.
Changes in physical fitness after 3 month exercise training. This will be measured by a cardiopulmonary exercise test with recording of maximal oxygen uptake during incremental exercise.
After 3 month exercise training
Secondary Outcomes (2)
Change from baseline of six minute walk
After 3 month exercise training
Change from baseline of NYHA class
After 3 month exercise training
Study Arms (2)
Exercise training
EXPERIMENTALProtocol of 3 month exercise training program.
Control
NO INTERVENTIONControl group
Interventions
Exercise training program for 3 months (two times a week).
Eligibility Criteria
You may qualify if:
- Clinical heart failure
- Preserved ejection fraction (\>50%)
- Stable clinically
- New York Heart Association Class II-III
You may not qualify if:
- Unable to exercise
- Other debilitating or unstable disease limiting length of life
- Implanted pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Meir Medical Centerlead
- Clalit Health Servicescollaborator
- Hadassah Medical Organizationcollaborator
Study Sites (1)
Hadassah University Hospital
Jerusalem, IL-91120, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Israel Gotsman, MD
Hadassah University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2011
First Posted
February 2, 2011
Study Start
March 1, 2011
Primary Completion
December 1, 2012
Study Completion
June 1, 2013
Last Updated
March 19, 2012
Record last verified: 2012-03